Doxazosin mesylate and Xalatan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Doxazosin mesylate (doxazosin mesylate) and Xalatan (latanoprost). Common drug interactions include vision blurred among females and cataract among males.

The phase IV clinical study analyzes what interactions people have when they take Doxazosin mesylate and Xalatan. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Doxazosin mesylate?

Doxazosin mesylate has active ingredients of doxazosin mesylate. It is often used in high blood pressure. eHealthMe is studying from 11,975 Doxazosin mesylate users. Check the latest studies of Doxazosin mesylate.

What is Xalatan?

Xalatan has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 25,550 Xalatan users. Check the latest studies of Xalatan.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 15, 2026

62 people who take Doxazosin mesylate and Xalatan together, and have interactions are studied.

Doxazosin mesylate and Xalatan drug interactions.

What are the common drug interactions of Doxazosin Mesylate and Xalatan, by gender? *:

female:

Vision blurred
Visual impairment
Bicytopenia (two parameters from the full blood count are low, the term bicytopenia can be used)
Renal failure acute (rapid kidney dysfunction)
Dehydration (dryness resulting from the removal of water)
Vomiting
Erythropenia (a deficiency in the number of red blood cells)
Hyperkalaemia (damage to or disease of the kidney)
Thrombocytopenia (decrease of platelets in blood)
Dyspnoea (difficult or laboured respiration)

male:

Cataract (clouding of the lens inside the eye)
Visual acuity reduced (reduced clearness of vision)
Cardiac disorder
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Fatigue (feeling of tiredness)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
In-stent coronary artery restenosis
Rash
Renal failure acute (rapid kidney dysfunction)

What are the common drug interactions of Doxazosin Mesylate and Xalatan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Bicytopenia (two parameters from the full blood count are low, the term bicytopenia can be used)
Renal failure acute (rapid kidney dysfunction)
Dyspnoea (difficult or laboured respiration)
Erythropenia (a deficiency in the number of red blood cells)
Hyperkalaemia (damage to or disease of the kidney)
Thrombocytopenia (decrease of platelets in blood)
Anal fistula
Blindness
Gastroenteritis (inflammation of stomach and intestine)
Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

Pain: 20 people, 32.26%
Type 2 Diabetes: 15 people, 24.19%
Hyperlipidaemia (presence of excess lipids in the blood): 15 people, 24.19%
Enlarged Prostate: 4 people, 6.45%
Cardiac Disorder: 4 people, 6.45%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Doxazosin mesylate and Xalatan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously